e-drug
[Top] [All Lists]

[e-drug] Prescrire International January issue

E-Drug: Prescrire International January issue

Dear colleagues

Go to www.english.prescrire.org<http://www.english.prescrire.org> for the 
contents of the latest issue of Prescrire International

Prescrire is a non-profit, continuing education organisation that is completely 
independent of any ties to government or industry. Prescrire's managers and 
editorial staff sign a yearly statement certifying that they have no conflicts 
of interest. Prescrire's publications accept no advertising, grants or other 
outside support or any kind.

Prescrire International is totally funded by subscribers, with no support from 
the pharmaceutical industry or government. It is monthly and published 11 times 
a year as of November 2010. Health professionals in low-income countries 
(excluding drug companies) can benefit from a subscription to Prescrire 
International thanks to Solidarity Subscription Rates.

You will find full subscription details at 
www.english.prescrire.org<http://www.english.prescrire.org>

Contents of the January issue include:


EDITORIAL
=========
Personalised service
FREE

NEW PRODUCTS
============

13-valent pneumococcal conjugate vaccine (New Drug)
Attractive, but close monitoring required
A 10-valent conjugate vaccine for some countries

Ketoprofen gels (Unacceptable)
Remain on the market in France and Europe, despite cutaneous adverse effects

Vinflunine (bladder cancer) (New Drug)
No benefit despite statistical manipulation

INN common stem : - dipine

ADVERSE EFFECTS
===============

Domperidone: QT prolongation in infants
Avoid using for mild regurgitation
FREE

Neuroleptics: swallowing disorders
Weight loss, potentially fatal aspiration pneumonia

Exenatide: excessive weight loss
Further undermines its role in type 2 diabetes

Saquinavir: prolongation of PR and QT intervals
Precautions are required in patients at risk

REVIEWS
=======

Adverse effects of cannabis
Inform psychologically vulnerable patients of the risk of serious, 
dose-dependent disorders

OUTLOOK
=======

DSM-V: madness !
Lower diagnostic thresholds and medicalisation of life
FREE

Targeting drug companies' bottom line
Off-label promotion: shifting a balance of power that benefits industry
FREE

End of life. Some patients want to discuss their prognosis and terminal care
A Canadian survey

Book review: Mediator° 150 mg
About the benfluorex scandal in France
FREE

Prescrire: A coherent database of reviews
FREE

Prescrire International now published 11 times a year. Full details at: 
www.english.prescrire.org<http://www.english.prescrire.org>


Bruno TOUSSAINT
Editorial Director
Prescrire.
75558 PARIS CEDEX 11
FRANCE



<Prev in Thread] Current Thread [Next in Thread>
  • [e-drug] Prescrire International January issue, international <=